@stvnews: Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a potential treatment for obese people with the respiratory condition, who are “often resistant” to steroids, researchers said. Weight-loss jabs, also known as glucagon-like peptide1 receptor-agonists (GLP1-RAs), work by mimicing the hormone GLP-1 to regulate blood sugar and insulin levels. They were initially developed as a treatment for people with type 2 diabetes. #news #Scotland #uk #weightloss #mounjaro

STV News

Open In TikTok:

Region: GB

Friday 25 July 2025 15:00:16 GMT